[ad_1]
“Compared to what was agreed at the end of February, this is a very significant reduction,” Gytis Andrulionis, head of IWT, told BNS on Friday.
Aistė Šuksta, a spokesperson for the Minister of Health, told BNS that this decrease would reach 39% in March, compared to the plan previously presented.
“In April 4% is expected to decline,” he said.
According to G. Anddrulionis, the British and Swedish vaccine manufacturer will supply a smaller quantity of vaccines to Lithuania and other European Union countries in the next two weeks due to “problems in the international supply chain”.
G. Anddrulionis stated that due to confidentiality obligations, it cannot disclose the exact quantity of vaccine supply to Lithuania.
“We ask the company itself to communicate this to us,” he said.
Last week, the Health Ministry informed BNS that the supply of AstraZeneca vaccines would be reduced by about a quarter to four months from March.
The country currently uses three COVID-19 vaccines approved by the European Medicines Agency (EMA): Pfizer and BioNTech, and Moderna and AstraZeneca.
The Johnson & Johnson vaccine was approved by EVA on Thursday. The first doses could reach Lithuania by the end of April. However, G. Anddrulionis states that the first shipments will be symbolic.
If you have any questions about the COVID-19 vaccine, please send them to our editorial staff by email. email address [email protected]
[ad_2]
